These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 17415196

  • 1. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA, Várallyay CG, Manninger S, Solymosi D, Haluska M, Hunt MA, Nesbit G, Stevens A, Jerosch-Herold M, Jacobs PM, Hoffman JM.
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S, Raslan AM, Muldoon LL, Hamilton BE, Rooney WD, Varallyay CG, Njus JM, Haluska M, Neuwelt EA.
    Int J Radiat Oncol Biol Phys; 2011 Feb 01; 79(2):514-23. PubMed ID: 20395065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
    Hamilton BE, Nesbit GM, Dosa E, Gahramanov S, Rooney B, Nesbit EG, Raines J, Neuwelt EA.
    AJR Am J Roentgenol; 2011 Oct 01; 197(4):981-8. PubMed ID: 21940589
    [Abstract] [Full Text] [Related]

  • 10. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.
    Bashir MR, Mody R, Neville A, Javan R, Seaman D, Kim CY, Gupta RT, Jaffe TA.
    J Magn Reson Imaging; 2014 Jul 01; 40(1):113-8. PubMed ID: 24130008
    [Abstract] [Full Text] [Related]

  • 11. MS-325: albumin-targeted contrast agent for MR angiography.
    Lauffer RB, Parmelee DJ, Dunham SU, Ouellet HS, Dolan RP, Witte S, McMurry TJ, Walovitch RC.
    Radiology; 1998 May 01; 207(2):529-38. PubMed ID: 9577506
    [Abstract] [Full Text] [Related]

  • 12. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.
    Acad Radiol; 2006 Jun 01; 13(6):744-51. PubMed ID: 16679277
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol.
    Dósa E, Guillaume DJ, Haluska M, Lacy CA, Hamilton BE, Njus JM, Rooney WD, Kraemer DF, Muldoon LL, Neuwelt EA.
    Neuro Oncol; 2011 Feb 01; 13(2):251-60. PubMed ID: 21163809
    [Abstract] [Full Text] [Related]

  • 14. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
    Aoki T, Saito M, Koseki H, Tsuji K, Tsuji A, Murata K, Kasuya H, Morita A, Narumiya S, Nozaki K, MR Macrophage Imaging Study Investigators.
    J Stroke Cerebrovasc Dis; 2017 Oct 01; 26(10):2055-2064. PubMed ID: 28774792
    [Abstract] [Full Text] [Related]

  • 15. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
    Krautmacher C, Willinek WA, Tschampa HJ, Born M, Träber F, Gieseke J, Textor HJ, Schild HH, Kuhl CK.
    Radiology; 2005 Dec 01; 237(3):1014-9. PubMed ID: 16237142
    [Abstract] [Full Text] [Related]

  • 16. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL, Mehndiratta A, Risse F, Rius M, Zechmann CM, von Tengg-Kobligk H, Gerigk L, Kauczor HU, Politi M, Essig M, Griffiths PD, Wilkinson ID.
    Acta Radiol; 2009 Jun 01; 50(5):521-30. PubMed ID: 19337867
    [Abstract] [Full Text] [Related]

  • 17. Combined T1-based perfusion MRI and MR angiography in kidney: first experience in normals and pathology.
    Dujardin M, Luypaert R, Vandenbroucke F, Van der Niepen P, Sourbron S, Verbeelen D, Stadnik T, de Mey J.
    Eur J Radiol; 2009 Mar 01; 69(3):542-9. PubMed ID: 18164570
    [Abstract] [Full Text] [Related]

  • 18. Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent.
    Bashir MR, Jaffe TA, Brennan TV, Patel UD, Ellis MJ.
    Transplantation; 2013 Jul 15; 96(1):91-6. PubMed ID: 23680931
    [Abstract] [Full Text] [Related]

  • 19. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R1 and R2* relaxometry.
    Rivera-Rivera LA, Schubert T, Knobloch G, Turski PA, Wieben O, Reeder SB, Johnson KM.
    Magn Reson Med; 2018 Jun 15; 79(6):3072-3081. PubMed ID: 29096054
    [Abstract] [Full Text] [Related]

  • 20. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P, Merigo F, Fiorini S, Nicolato E, Tambalo S, Daducci A, Degrassi A, Sbarbati A, Rubello D, Marzola P.
    Eur J Radiol; 2011 Apr 15; 78(1):52-9. PubMed ID: 19443159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.